GT200600520A - Agentes antibacterianos - Google Patents
Agentes antibacterianosInfo
- Publication number
- GT200600520A GT200600520A GT200600520A GT200600520A GT200600520A GT 200600520 A GT200600520 A GT 200600520A GT 200600520 A GT200600520 A GT 200600520A GT 200600520 A GT200600520 A GT 200600520A GT 200600520 A GT200600520 A GT 200600520A
- Authority
- GT
- Guatemala
- Prior art keywords
- compounds
- antibacterial agents
- methods
- antibacterial
- prepare
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75326205P | 2005-12-22 | 2005-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200600520A true GT200600520A (es) | 2007-07-17 |
Family
ID=37872452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200600520A GT200600520A (es) | 2005-12-22 | 2006-12-20 | Agentes antibacterianos |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7557100B2 (https=) |
| EP (2) | EP1971612A1 (https=) |
| JP (1) | JP5513743B2 (https=) |
| AR (1) | AR058701A1 (https=) |
| CA (1) | CA2634644A1 (https=) |
| DO (1) | DOP2006000268A (https=) |
| GT (1) | GT200600520A (https=) |
| NL (1) | NL2000373C2 (https=) |
| PE (1) | PE20071137A1 (https=) |
| TW (1) | TW200734344A (https=) |
| UY (1) | UY30030A1 (https=) |
| WO (1) | WO2007072151A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2552682T3 (es) | 2003-03-10 | 2015-12-01 | Merck Sharp & Dohme Corp. | Agentes antibacterianos novedosos |
| DOP2006000268A (es) * | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
| US20100261719A1 (en) * | 2007-07-02 | 2010-10-14 | Gregory Steven Basarab | Chemical compounds |
| CA2729923A1 (en) * | 2007-07-06 | 2009-01-15 | Aarhus Universitet | Dehydrated chitosan nanoparticles |
| CN101687871A (zh) | 2007-07-16 | 2010-03-31 | 阿斯利康(瑞典)有限公司 | 用作抗菌剂的螺缩合巴比妥酸衍生物 |
| CN105732745A (zh) | 2007-10-25 | 2016-07-06 | 森普拉制药公司 | 大环内酯类抗菌剂的制备方法 |
| US9040528B2 (en) | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
| CN102245605B (zh) * | 2008-10-14 | 2016-01-27 | 阿斯利康(瑞典)有限公司 | 用于治疗细菌感染的稠合、螺环杂芳族化合物 |
| AU2009308182B2 (en) * | 2008-10-24 | 2016-05-19 | Cempra Pharmaceuticals, Inc. | Biodefenses using triazole-containing macrolides |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| US9480679B2 (en) | 2009-09-10 | 2016-11-01 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and MAC diseases |
| DK2550286T3 (en) | 2010-03-22 | 2016-02-29 | Cempra Pharmaceuticals Inc | CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF |
| CN105198944B (zh) | 2010-05-20 | 2018-06-01 | 森普拉制药公司 | 制备大环内酯和酮内酯及其中间体的方法 |
| EP2613630A4 (en) | 2010-09-10 | 2014-01-15 | Cempra Pharmaceuticals Inc | HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES |
| MX2014011537A (es) | 2012-03-27 | 2015-02-10 | Cempra Pharmaceuticals Inc | Formulaciones parenterales para la administracion de antibioticos macrolidos. |
| US8952149B2 (en) | 2012-09-26 | 2015-02-10 | Zoetis Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| US8889671B2 (en) | 2013-01-23 | 2014-11-18 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
| HK1217665A1 (zh) | 2013-03-14 | 2017-01-20 | 森普拉制药公司 | 用於治療呼吸道疾病的方法及其製劑 |
| RU2015138797A (ru) | 2013-03-15 | 2017-04-24 | Семпра Фармасьютикалс, Инк. | Конвергентные способы получения макролидных антибактериальных агентов |
| SG10201906842WA (en) | 2014-05-29 | 2019-08-27 | Entasis Therapeutics Ltd | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| UY36851A (es) | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | Compuestos para uso en aplicaciones antibacterianas |
| KR102717819B1 (ko) | 2017-07-28 | 2024-10-14 | 다케다 야쿠힌 고교 가부시키가이샤 | Tyk2 억제제 및 이의 용도 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5011860A (en) | 1986-04-11 | 1991-04-30 | Schering Corporation | Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases |
| DE19502178A1 (de) | 1994-01-27 | 1995-08-03 | Hoechst Ag | Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen |
| US6608081B2 (en) * | 1999-08-12 | 2003-08-19 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| CN1501937A (zh) | 2000-10-26 | 2004-06-02 | �Ʒ� | 螺-嘧啶-2,4,6-三酮金属蛋白酶抑制剂 |
| ATE315038T1 (de) * | 2001-05-30 | 2006-02-15 | Warner Lambert Co | Antibakterielle mittel |
| AU2003228701A1 (en) | 2002-04-25 | 2003-11-10 | Bristol-Myers Squibb Company | Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases |
| US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| CA2606847A1 (en) | 2005-05-09 | 2006-11-16 | Warner-Lambert Company Llc | Antibacterial agents |
| DOP2006000268A (es) * | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
-
2006
- 2006-11-29 DO DO2006000268A patent/DOP2006000268A/es unknown
- 2006-12-11 WO PCT/IB2006/003641 patent/WO2007072151A1/en not_active Ceased
- 2006-12-11 CA CA002634644A patent/CA2634644A1/en not_active Abandoned
- 2006-12-11 EP EP06831728A patent/EP1971612A1/en not_active Withdrawn
- 2006-12-11 JP JP2008546665A patent/JP5513743B2/ja not_active Expired - Fee Related
- 2006-12-11 EP EP13151044.8A patent/EP2620439A1/en not_active Withdrawn
- 2006-12-13 NL NL2000373A patent/NL2000373C2/nl not_active IP Right Cessation
- 2006-12-19 UY UY30030A patent/UY30030A1/es not_active Application Discontinuation
- 2006-12-19 US US11/641,215 patent/US7557100B2/en not_active Expired - Fee Related
- 2006-12-20 AR ARP060105669A patent/AR058701A1/es unknown
- 2006-12-20 PE PE2006001657A patent/PE20071137A1/es not_active Application Discontinuation
- 2006-12-20 GT GT200600520A patent/GT200600520A/es unknown
- 2006-12-21 TW TW095148255A patent/TW200734344A/zh unknown
-
2009
- 2009-07-15 US US12/503,123 patent/US20090275536A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| UY30030A1 (es) | 2007-07-31 |
| NL2000373A1 (nl) | 2007-06-26 |
| CA2634644A1 (en) | 2007-06-28 |
| US20090275536A1 (en) | 2009-11-05 |
| US7557100B2 (en) | 2009-07-07 |
| AR058701A1 (es) | 2008-02-20 |
| TW200734344A (en) | 2007-09-16 |
| NL2000373C2 (nl) | 2010-02-02 |
| US20070197518A1 (en) | 2007-08-23 |
| DOP2006000268A (es) | 2007-07-31 |
| WO2007072151A1 (en) | 2007-06-28 |
| JP5513743B2 (ja) | 2014-06-04 |
| PE20071137A1 (es) | 2008-01-10 |
| JP2009520804A (ja) | 2009-05-28 |
| EP1971612A1 (en) | 2008-09-24 |
| EP2620439A1 (en) | 2013-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200600520A (es) | Agentes antibacterianos | |
| UY31673A1 (es) | "derivados heterocíclicos de urea y métodos de uso de los mismos-211" | |
| BRPI0810064B8 (pt) | compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos | |
| NO20082191L (no) | Forbindelser | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| UY30759A1 (es) | Compuestos quimicos | |
| EA200901617A1 (ru) | Борсодержащие молекулы небольшого размера | |
| ECSP088763A (es) | Nuevas combinaciones terapéuticas para el tratamiento de la depresión | |
| ECSP099634A (es) | Derivados de piridazinona útiles como inhibidores de glucano sintasa | |
| CL2008001373A1 (es) | Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer. | |
| CL2008001656A1 (es) | Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene. | |
| EA033311B1 (ru) | Производные бензоксаборола в качестве антибактериальных средств | |
| CL2008001633A1 (es) | Compuestos derivados de pirrolidin-3-carboxamida; composición farmacéutica; y uso comominhibidores de erk para el tratamiento del cancer. | |
| BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
| UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
| GT200900201A (es) | Formulaciones para el tratamiento del cáncer. | |
| BRPI0718688A2 (pt) | Composições de baixa irritação e métodos para preparar as mesmas. | |
| GT201000047A (es) | Mejoras en compuestos organicos o relacionadas con los mismos | |
| PA8855001A1 (es) | Monocarbamas | |
| CL2008003284A1 (es) | Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras. | |
| BRPI0815920A2 (pt) | Composto, composição farmacêutica, e, uso do composto. | |
| BRPI0922233A2 (pt) | compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas. | |
| NO20075111L (no) | Farmasoytisk sammensetning | |
| CL2007003232A1 (es) | Compuestos derivados de 5-hidroximetil oxazolidin-2-ona; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar y prevenir infecciones bacterianas. | |
| UY30544A1 (es) | Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones |